ATE231867T1 - Stereoselektives verfahren zur herstellung von dihydro-2,3-benzodiazepin-derivaten - Google Patents

Stereoselektives verfahren zur herstellung von dihydro-2,3-benzodiazepin-derivaten

Info

Publication number
ATE231867T1
ATE231867T1 AT95306051T AT95306051T ATE231867T1 AT E231867 T1 ATE231867 T1 AT E231867T1 AT 95306051 T AT95306051 T AT 95306051T AT 95306051 T AT95306051 T AT 95306051T AT E231867 T1 ATE231867 T1 AT E231867T1
Authority
AT
Austria
Prior art keywords
benzodiazepine derivatives
stereoselective process
producing dihydro
dihydro
producing
Prior art date
Application number
AT95306051T
Other languages
English (en)
Inventor
Benjamin Anderson
Marvin Martin Hansen
Jeffrey Thomas Vicenzi
David Lee Varie
Milton Joseph Zmijewski
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/413,036 external-priority patent/US5665878A/en
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Application granted granted Critical
Publication of ATE231867T1 publication Critical patent/ATE231867T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C07D491/056—Ortho-condensed systems with two or more oxygen atoms as ring hetero atoms in the oxygen-containing ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/58—Radicals substituted by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT95306051T 1994-08-31 1995-08-30 Stereoselektives verfahren zur herstellung von dihydro-2,3-benzodiazepin-derivaten ATE231867T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US29864594A 1994-08-31 1994-08-31
US08/413,036 US5665878A (en) 1994-08-31 1995-03-28 Stereoselective process for producing dihydro-2,3-benzodiazepine derivatives

Publications (1)

Publication Number Publication Date
ATE231867T1 true ATE231867T1 (de) 2003-02-15

Family

ID=26970799

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95306051T ATE231867T1 (de) 1994-08-31 1995-08-30 Stereoselektives verfahren zur herstellung von dihydro-2,3-benzodiazepin-derivaten

Country Status (22)

Country Link
US (3) US5919954A (de)
EP (1) EP0699677B1 (de)
JP (1) JP3481019B2 (de)
KR (1) KR100399518B1 (de)
CN (1) CN1086705C (de)
AT (1) ATE231867T1 (de)
AU (1) AU702658B2 (de)
BR (1) BR9503845A (de)
CA (1) CA2157234C (de)
CZ (1) CZ295675B6 (de)
DE (1) DE69529499T2 (de)
DK (1) DK0699677T3 (de)
ES (1) ES2189819T3 (de)
FI (1) FI113269B (de)
HK (1) HK1013818A1 (de)
HU (1) HU223776B1 (de)
IL (1) IL115100A (de)
IN (1) IN190402B (de)
NO (1) NO312838B1 (de)
PL (3) PL188796B1 (de)
RU (1) RU2151149C1 (de)
TR (1) TR199501071A2 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE255112T1 (de) * 1997-08-12 2003-12-15 Egyt Gyogyszervegyeszeti Gyar 1-3 dioxolo/4.5-h//2,3-benzodiazepin derivate als ampa/kainate-rezeptor-hemmer
UA67749C2 (uk) * 1997-08-12 2004-07-15 Егіш Дьйодьсердьяр Рт. Похідна 8-заміщеного-9н-1,3-діоксол/4,5-h//2,3/бензодіазепіну з властивостями амра/каїнатного антагоніста, спосіб одержання похідних, фармацевтична композиція (варіанти), спосіб її одержання та спосіб лікування
AU1302999A (en) * 1997-11-04 1999-05-24 Eli Lilly And Company Ketoreductase gene and protein from yeast
US20030219456A1 (en) * 2002-05-21 2003-11-27 Taing Ok Method of utilization of zygosaccharomyces rouxii
US6858605B2 (en) 2003-02-04 2005-02-22 Ivax Drug Research Institute, Ltd. Substituted 2,3-benzodiazepine derivatives
DE502005006892D1 (de) * 2005-12-05 2009-04-30 Deutsche Post Ag Verfahren zum Sortieren von Postsendungen und Vorrichtung mit einer Datenstruktur für einen Sortierplan
EP1979308A1 (de) * 2005-12-30 2008-10-15 EGIS Gyógyszergyár Nyrt Optische isomere von dihydro-2,3-benzodiazepinen und ihre stereoselektive synthese
KR100841592B1 (ko) 2007-04-16 2008-06-26 한양대학교 산학협력단 벤조디옥솔 유도체와 이의 제조방법

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3794642A (en) * 1973-01-15 1974-02-26 Lilly Co Eli Oxidation of substituted methanes to the corresponding substituted methanols
DE2816475A1 (de) * 1978-04-15 1979-10-25 Bayer Ag Isochroman-derivate, verfahren zu ihrer herstellung und ihre verwendung als synergisten in insektiziden und akariziden mitteln
US4358041A (en) 1980-06-12 1982-11-09 Olin Corporation Powder-actuated tool with power adjustment and angle-fire control
HU191702B (en) * 1984-06-27 1987-03-30 Gyogyszerkutato Intezet New process for preparing 1-aryl-5 h-2,3-benzodiazepines
HU191698B (en) * 1984-07-27 1987-03-30 Gyogyszerkutato Intezet Process for producing new 1-aryl-5h-2beta-benzodiazepines
HU198494B (en) 1986-08-15 1989-10-30 Gyogyszerkutato Intezet Process for producing new 3,4-dihydro-5h-2,3-benzodiazepine derivative and acid addition salts thereof, as well as pharmaceutical compositions comprising same
DE68926417T2 (de) * 1988-02-12 1996-09-12 Daicel Chem Verfahren zur herstellung von optisch aktiven 2-hydroxysäureabkömmlingen
JP2679145B2 (ja) * 1988-09-02 1997-11-19 ダイセル化学工業株式会社 オキシケトンの製造法
HU219778B (hu) * 1990-12-21 2001-07-30 Gyógyszerkutató Intézet Közös Vállalat Eljárás N-acil-2,3-benzodiazepin-származékok, savaddíciós sóik és az ezeket tartalmazó gyógyászati készítmények előállítására, valamint a vegyületek egy csoportja, és az ezeket tartalmazó gyógyászati készítmények
HU206719B (en) 1990-12-21 1992-12-28 Gyogyszerkutato Intezet Process for producing 1-/4-acylamino-phenyl/-7,8-methylenedioxy-5h-2,3-benzodiazepine derivatives, acid addicional salts and pharmaceutical compositions containing them
JP3061422B2 (ja) * 1990-12-27 2000-07-10 ダイセル化学工業株式会社 光学活性（ｓ）−２−クロロ−１−フェニルプロパノールの製造法
JPH04271789A (ja) * 1991-01-10 1992-09-28 Takeda Chem Ind Ltd Ｄ−パントラクトンの製造方法
HU219777B (hu) * 1993-07-02 2001-07-30 Gyógyszerkutató Intézet Kft. Optikailag aktív 1-(4-nitro-fenil)-4-metil-7,8-metiléndioxi-3,4-dihidro-5H-2,3-benzodiazepin és eljárás előállítására

Also Published As

Publication number Publication date
CZ221995A3 (en) 1996-03-13
NO312838B1 (no) 2002-07-08
AU702658B2 (en) 1999-02-25
CN1123282A (zh) 1996-05-29
PL188796B1 (pl) 2005-04-29
NO953396L (no) 1996-03-01
CZ295675B6 (cs) 2005-09-14
HUT72644A (en) 1996-05-28
BR9503845A (pt) 1996-04-16
TR199501071A2 (tr) 1996-06-21
DE69529499T2 (de) 2003-12-04
PL190640B1 (pl) 2005-12-30
JPH0881468A (ja) 1996-03-26
CA2157234C (en) 2005-05-03
HU9502545D0 (en) 1995-10-30
IN190402B (de) 2003-07-26
PL310226A1 (en) 1996-03-04
EP0699677A1 (de) 1996-03-06
RU2151149C1 (ru) 2000-06-20
IL115100A (en) 2000-07-26
NO953396D0 (no) 1995-08-30
FI954064A (fi) 1996-03-01
FI954064A0 (fi) 1995-08-30
KR100399518B1 (ko) 2004-04-30
US5919954A (en) 1999-07-06
DE69529499D1 (de) 2003-03-06
US6160133A (en) 2000-12-12
ES2189819T3 (es) 2003-07-16
PL190318B1 (pl) 2005-11-30
IL115100A0 (en) 1995-12-08
US5986114A (en) 1999-11-16
AU3035595A (en) 1996-03-14
CN1086705C (zh) 2002-06-26
FI113269B (fi) 2004-03-31
JP3481019B2 (ja) 2003-12-22
HK1013818A1 (en) 1999-09-10
KR960007595A (ko) 1996-03-22
CA2157234A1 (en) 1996-03-01
HU223776B1 (hu) 2005-01-28
EP0699677B1 (de) 2003-01-29
DK0699677T3 (da) 2003-04-22

Similar Documents

Publication Publication Date Title
ATE174903T1 (de) Neues verfahren zur herstellung von 7- (substituierten)-9-((substistuierter
PT778277E (pt) Derivados heterociclicos substituidos como antagonistas do crf
DE69233106D1 (de) Verfahren zur Herstellung von Einzelsträndigen "stem-loop" DNS
DE69231815D1 (de) Verfahren zur Herstellung von Cephalosporinen und Zwischenprodukte in diesem Verfahren
ATE231867T1 (de) Stereoselektives verfahren zur herstellung von dihydro-2,3-benzodiazepin-derivaten
ATE197150T1 (de) Verfahren zur herstellung von dihydroxypyrimidin- derivaten
DE69704832D1 (de) Verfahren zur Herstellung von Pyrimidinderivaten
DE69618387D1 (de) Verfahren zur Herstellung von Caprolactam aus Aminocapronitril
DE69925992D1 (de) VERFAHREN ZUR HERSTELLUNG VON 5-HYDROXYBENZO[b]THIOPHEN-3-CARBONSÄURE
MY117754A (en) Stereoselective process for producing dihydro-2, 3-benzodiazepine derivatives
GB9202139D0 (en) Improvements in or relating to organic compounds
DE59611076D1 (de) Verfahren zur herstellung von 5,6-dihydro-1,3-oxazinen
ATE247641T1 (de) Pyridin-zwischenprodukte, verwendbar zur herstellung von beta-adrenergischen rezeptor- agonisten
ATE154022T1 (de) Verfahren zur herstellung von epibatidin
DE69223156D1 (de) Verfahren zur herstellung von enantiomer reinem imidazo (4,5,1-jk) (1,4)-benzodiazepin-2(1h)-thionen
ATE159246T1 (de) Verfahren zur herstellung von (s)-vinyl- und (s)- allenyl-gaba
ATE133656T1 (de) Verfahren zur herstellung von 2-amino-5,6- dimethoxy tetralin
DE69816773D1 (de) Verfahren zur herstellung von 1,4-benzodioxan-derivaten
DE59502722D1 (de) Verfahren und Zwischenprodukte zur Herstellung von 5-Oxaspiro [2.4] heptan-6-on
DE60035194D1 (de) Verfahren zur herstellung von indol-derivaten und intermediaten dafür
DK0949250T3 (da) Fremgangsmåde til fremstilling af alpha1L-adrenoceptorantagonister
DE3683352D1 (de) Verfahren zur herstellung von indolinen.
DE3864463D1 (de) Gamma-l-glutanyl-4-nitoanilid-derivate und verfahren zur bestimmung von gamma-gtp-aktivitaet unter verwendung dieser derivate.
DE3667464D1 (de) Verfahren zur herstellung von 2-acyl-3,4-dialkoxyanilinen.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0699677

Country of ref document: EP

REN Ceased due to non-payment of the annual fee